Eli Lilly won’t lose its grip on the weight loss market despite recent investor concerns. Meanwhile, Zocdoc releases an AI-powered scheduling assistant.

Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...

Novo Nordisk Q1 sales missed estimates despite strong growth in Wegovy and Ozempic, prompting a cut to its 2025 guidance amid ...

Health insurers, employers and pharmacy benefit managers may be insulated from the immediate effects of drug tariffs, but ...

CVS stock has an attractive yield and earnings expansion. That makes it worth a look for investors seeking growth and income.

Consumers, doctors and other advocates agree pharmacy benefit managers (PBMs) wield too much power and influence over patients’ access to medicines and their prices.

Stephen Diroux with Wurlitzer Family Pharmacy says it’s a tragedy to see Rite Aid leave New York, however, this outlines a ...

Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...

Vinay Prasad, an academic and fierce critic of the medical mainstream, has been chosen to be the next director of the FDA ...

Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Shoppers at Tesco were greeted with warm smiles and useful information on Saturday 3rd May, as Caremark set up a welcoming ...